|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 12795315.6 (espacenet) (Federated) (European Patent Register), 20121129 | | Patent/reg. no. and date | DK/EP 2787995, 20160817 | | Publication date | 20141015 | | Priority no. and date | US 201161567242 P, 20111206 | | EP pub. no. and date |
EP 2787995 20141015 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | P81603805DK00E | | Inventor | KEHN, Linda Rorick, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/435 (2006.01) , A61P 25/32 (2006.01) | | Title | Spirothienopyranpiperidin-derivater som ORL-1 receptorantagonister til anvendelse ved behandling af alkoholafhængighed og -misbrug | | Int. application no. | US2012066918 | | Int. publication no. | WO2013085781 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
